The Mentor with Mark Bouris

With Stake, Australia's leading investing platform, I'm excited to share the tenth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.Join us as we dive into the world of Nick Langton, a former financial services executive turned entrepreneur, now the CEO of Alta. In this episode, we explore Alta's journey from inception to going public on the NYSE and reaching a market cap of $42.3 million. Discover how Alta is shaking up combat sports fitness with tech-powered training, available both in-gym and at home. They've now partnered with over 500 gyms! We'll also discuss how MMA icons Conor McGregor, John Kavanagh, Laura Sanko and Daniel Cormier are involved.Earlier this year, Alta was listed on the New York Stock Exchange with the ticker MMA.DISCLAIMER:Views expressed are those of the individual only. This does not constitute financial advice. You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj. Join the Facebook Group.Follow Mark Bouris on Instagram, LinkedIn & YouTube. See omnystudio.com/listener for privacy information.

Odette Barry is a seasoned publicist, Public Relations mentor, and the Director of Odette & Co, a thriving PR and digital marketing agency based in Byron Bay.With over 15 years of industry experience, Odette has honed her expertise in crafting compelling narratives and amplifying the voices of businesses across various sectors.Now as the head honcho of Odette & Co, Odette is dedicated to fostering strong relationships with clients and her talented team, embodying a collaborative approach grounded in trust and integrity. Her consultancy arm has garnered acclaim for its ability to tackle complex communications challenges and deliver tangible results for clients spanning the technology, education, beauty, wellness, health, and fashion sectors.We spoke about how PR has evolved, creating the right relationships, the importance of controlling your own story, how most marketing boils down to common sense, her work with startups, handling PR disasters, and much more.Learn more about Odette's work here:https://www.odetteandco.com.au/You can subscribe to the newsletter here: https://mentored.com.au/newsletter-sign-upJoin the Facebook Group.Follow Mark Bouris on Instagram, LinkedIn & YouTube. 

This Sunday close to 120,000 people worldwide will ride motorcycles dressed sharply, all in support of raising funds and awareness for research into men's mental health and prostate cancer.The Distinguished Gentleman's Ride is a globally acclaimed motorcycle gathering, with its inaugural event in Sydney back in 2012.Over the years, the event has achieved remarkable success, having raised an impressive $50 million USD from the participation of 340,000 riders across 115 countries.It was awesome to speak to Mark Hawwa, the visionary and creator of the global event on The Mentor.Our conversation delved into our shared passion for motorcycles, the inception of the Distinguished Gentleman's Ride (DGR), reshaping the perception of motorcyclists, the alarming rates of mental health challenges and prostate cancer among men, the strategic business approach driving DGR, Mark's journey in scaling and fostering the expansive community of DGR, and much more.If you want to learn more about the Distinguished Gentleman's Ride or donate to the cause, see their website here: https://www.gentlemansride.com/You can subscribe to the newsletter here: https://mentored.com.au/newsletter-sign-upJoin the Facebook Group.Follow Mark Bouris on Instagram, LinkedIn & YouTube. 

Discover the inspiring story behind Ārepa, a venture born out of a quest to revolutionise brain health. Co-founders Angus Brown and Zac Robinson were driven by personal losses to create healthier energy drink alternatives. The duo partnered with renowned neuroscientist Professor Andrew Scholey to develop a groundbreaking range of natural, caffeine-free products crafted from New Zealand Blackcurrants and Bark.In this episode, I speak to Angus & Professor Scholey; we delve into the journey of Ārepa, from its humble beginnings to its emergence as a game-changer in brain health. Professor Scholey shares his expertise in human psychopharmacology and how it has shaped the scientific development of Ārepa, ensuring its effectiveness and safety. We also explore the concept of 'flow state', Ārepa's role in enhancing cognitive function, attracting attention from elite athletes and high-profile clientele worldwide.Tune in as we discuss the complexities of the human brain, the science behind Ārepa's products, how they've bottled the "flow state", their vision for reshaping the energy drink industry, the potential Ārepa has to make a lasting impact and much more.You can subscribe to the newsletter here: https://mentored.com.au/newsletter-sign-upJoin the Facebook Group.Follow Mark Bouris on Instagram, LinkedIn & YouTube. 

Tim Duggan is a pioneering entrepreneur who co-founded Junkee Media, Australia’s leading digital publisher for Millennials. Tim's career began as a music journalist for Rolling Stone, and he has since written award-winning books like "Cult Status" and "Killer Thinking." His latest book, "Work Backwards," offers insights into rethinking traditional work models.In this episode of The Mentor, Tim discusses his journey from journalism to entrepreneurship, the success of Junkee Media, his thoughts on work/life balance, and his award-winning books. He also shares his outlook on the future of work and the potential for re-entering the media landscape.You can subscribe to the newsletter here: https://mentored.com.au/newsletter-sign-upJoin the Facebook Group.Follow Mark Bouris on Instagram, LinkedIn & YouTube. 

With Stake, Australia's leading investing platform, I'm excited to share the ninth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.This podcast will delve into the journey of James Graham, one of the youngest CEOs in Australia's public company sector. At 34, James leads Recce Pharmaceuticals (ASX:RCE), a rapidly growing medical technology firm taking on antibiotic resistance, a global health crisis.We explore the highs and lows of building a biotech company, the road to going public, and the impact of Recce's novel approach to fighting infectious diseases. Get insights into James' journey from startup entrepreneur to industry leader, his perspectives on global health, and his vision for making a lasting impact.In 2016, Recce was listed on the Australian Securities Exchange with the stock ticker RCE.DISCLAIMER:Views expressed are those of the individual only. This does not constitute financial advice. You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj. Join the Facebook Group.Follow Mark Bouris on Instagram, LinkedIn & YouTube. See omnystudio.com/listener for privacy information.